CTXR
Citius Pharmaceuticals Inc
NASDAQ: CTXR · HEALTHCARE · BIOTECHNOLOGY
$0.70
+16.96% today
Updated 2026-04-30
Market cap
$17.23M
P/E ratio
—
P/S ratio
4.37x
EPS (TTM)
$-2.46
Dividend yield
—
52W range
$1 – $2
Volume
0.7M
Citius Pharmaceuticals Inc (CTXR) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | $0.00 | $0.00 | $1343.00 | $2632.00 | $1753.00 | $893.00 | $152364.00 | $164868.00 | $179677.00 | $194316.00 | $209611.00 | $214250.00 |
| Gross profit | — | — | — | $0.00 | $0.00 | $-1343.00 | $-2632.00 | $-1753.00 | $-893.00 | $-152364.00 | $-164868.00 | $-179677.00 | $-194316.00 | $-209611.00 | $-214250.00 |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| R&D | — | $705.00 | $492136.00 | $437971.00 | $1.80M | $2.93M | $2.94M | $6.56M | $8.60M | $8.81M | $12.24M | $17.66M | $14.82M | $11.91M | $9.16M |
| SG&A | $25637.00 | $19618.00 | $28118.00 | $715025.00 | $1.43M | $4.52M | $7.05M | $7.23M | $7.00M | $8.90M | $11.29M | $15.66M | $21.91M | $18.25M | $18.53M |
| Operating income | $-25637.00 | $-19618.00 | $-28118.00 | $-1.15M | $-3.23M | $-7.45M | $-9.99M | $-13.79M | $-15.60M | $-17.71M | $-23.53M | $-33.32M | $-36.73M | $-42.00M | $-38.53M |
| Operating margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | $-24933.00 | $-19618.00 | $-28118.00 | — | $-3.23M | $-7.45M | $-9.98M | $-13.79M | $-15.54M | $-17.38M | $-22.88M | $-32.88M | $-31.77M | $-38.64M | $-38.20M |
| EBITDA margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBIT | $-25637.00 | $-19618.00 | $-28118.00 | $-1.15M | $-3.23M | $-7.45M | $-9.99M | $-13.79M | $-15.55M | $-17.53M | $-23.04M | $-33.06M | $-31.97M | $-38.85M | $-38.42M |
| Interest expense | $0.00 | $2388.00 | $3251.00 | $0.00 | $7500.00 | $8994.00 | $850789.00 | $15838.00 | $16443.00 | $15673.00 | $10839.00 | $251399.00 | — | — | $267782.00 |
| Income tax | — | $-1016.00 | $-1.18M | $-119145.00 | $4434.00 | $8994.00 | $850789.00 | $1.28M | $16443.00 | $125880.00 | $70756.00 | $576000.00 | $576000.00 | $576000.00 | $1.06M |
| Effective tax rate | 0.0% | 4.4% | 97.4% | 8.6% | -0.2% | -0.1% | -8.9% | -11.4% | -0.1% | -0.7% | -0.3% | -1.7% | -1.8% | -1.5% | -2.9% |
| Net income | $-26341.00 | $-22006.00 | $-31369.00 | $-1.27M | $-2.90M | $-8.30M | $-10.38M | $-12.54M | $-15.58M | $-17.55M | $-23.13M | $-33.64M | $-32.54M | $-39.14M | $-37.43M |
| Net income growth (YoY) | — | +16.5% | -42.5% | -3955.4% | -128.1% | -185.8% | -25.2% | -20.7% | -24.3% | -12.6% | -31.8% | -45.5% | +3.3% | -20.3% | +4.4% |
| Profit margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |